Fig. 6From: Pharmacokinetics and biodistribution of a novel anticancer thyrointegrin αvβ3 antagonist: triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol (P-bi-TAT)Standard curve for P-bi-TAT with IS by positive LC-MS/MSBack to article page